AR086185A1 - ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A SPECIFIC PATIENT SUB-POPULATION - Google Patents
ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A SPECIFIC PATIENT SUB-POPULATIONInfo
- Publication number
- AR086185A1 AR086185A1 ARP120101348A AR086185A1 AR 086185 A1 AR086185 A1 AR 086185A1 AR P120101348 A ARP120101348 A AR P120101348A AR 086185 A1 AR086185 A1 AR 086185A1
- Authority
- AR
- Argentina
- Prior art keywords
- population
- hcv infection
- specific patient
- combined therapy
- formula
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 229960000329 ribavirin Drugs 0.000 abstract 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicación 1: Un método de tratamiento de infección viral por hepatitis C (HCV) o alivio de uno o varios de sus síntomas en un paciente, caracterizado porque comprende la etapa de administración al paciente de una combinación terapéutica que comprende: (a) un compuesto de la fórmula (1) o una de sus sales farmacéuticamente aceptables, en donde B es un resto de fórmula (3); L0 es MeO-; L1 es Br; y R2 es un resto de fórmula (4); (b) un compuesto de la fórmula (2) o de sus sales farmacéuticamente aceptables; y opcionalmente (c) ribavirina; y en donde el paciente tiene una enfermedad hepática compensada.Claim 1: A method of treating hepatitis C viral infection (HCV) or alleviating one or more of its symptoms in a patient, characterized in that it comprises the stage of administration to the patient of a therapeutic combination comprising: (a) a compound of the formula (1) or a pharmaceutically acceptable salt thereof, wherein B is a residue of formula (3); L0 is MeO-; L1 is Br; and R2 is a residue of formula (4); (b) a compound of the formula (2) or its pharmaceutically acceptable salts; and optionally (c) ribavirin; and where the patient has a compensated liver disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120101348 AR086185A1 (en) | 2012-04-19 | 2012-04-19 | ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A SPECIFIC PATIENT SUB-POPULATION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120101348 AR086185A1 (en) | 2012-04-19 | 2012-04-19 | ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A SPECIFIC PATIENT SUB-POPULATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR086185A1 true AR086185A1 (en) | 2013-11-27 |
Family
ID=50185255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120101348 AR086185A1 (en) | 2012-04-19 | 2012-04-19 | ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A SPECIFIC PATIENT SUB-POPULATION |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR086185A1 (en) |
-
2012
- 2012-04-19 AR ARP120101348 patent/AR086185A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014002171A (en) | COMBINATION TREATMENTS FOR HEPATITIS C. | |
| EA201991174A1 (en) | COMBINATION OF TWO ANTIVIRAL DRUGS FOR TREATMENT OF HEPATITIS C | |
| ECSP14013189A (en) | INHIBITORS OF THE REPLICATION OF VIRUSES OF THE FLU | |
| UY33897A (en) | HEPATITIS C VIRUS INHIBITORS | |
| EA201200096A1 (en) | PHARMACEUTICAL COMPOSITION OF THE HYPATITIS VIRUS PROTEASE INHIBITOR INHIBITOR | |
| EA201490419A1 (en) | COMPOUNDS FOR THE TREATMENT AND PREVENTION OF RESPIRATORY SYNCIAL VIRAL DISEASE | |
| RU2013119607A (en) | POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION FOR TREATMENT OF VIRAL DISEASES | |
| MX2014014117A (en) | D-AMINO ACIDS COMPOUNDS FOR LIVER DISEASES. | |
| EA201290576A1 (en) | FLAVIVIRIDAE VIRUS INHIBITORS | |
| UY32124A (en) | COMBINED THERAPY TO TREAT HCV INFECTION | |
| AR101740A1 (en) | COMBINATION AND COMPOSITION THERAPY | |
| RU2015114543A (en) | HEPATITIS TREATMENT METHODS | |
| PE20150161A1 (en) | USE OF HIGH DOSE LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
| EA201391685A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| BR112014013972A8 (en) | hcv inhibitors nssa | |
| ECSP13012551A (en) | COMBINATION THERAPY TO TREAT HCV INFECTION. | |
| RU2015114566A (en) | HEPATITIS TREATMENT METHODS | |
| CO7131387A2 (en) | Compositions and methods of oligonucleotide chelate complex-polypeptides | |
| EA201170605A1 (en) | CYCLONE DECADEPSYPE COMPOUNDS AND APPLICATION OF THE SPECIFIED COMPOUNDS AS A MEDICINE | |
| DOP2014000030A (en) | PROCEDURES FOR THE MANUFACTURE OF USEFUL DRUGS FOR THE TREATMENT OF VIRAL INFECTIONS | |
| AR091421A1 (en) | COMBINED THERAPEUTIC COMPOSITION TO TREAT HEPATITIS C | |
| AR086185A1 (en) | ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A SPECIFIC PATIENT SUB-POPULATION | |
| EA201692514A1 (en) | PHARMACEUTICAL COMPOSITIONS ON THE BASIS OF SOFOSBUVIR AND RIBAVIRIN WITH MODIFIED FREEDOM | |
| AR086186A1 (en) | ORAL COMBINED THERAPY TO TREAT HCV INFECTION IN A POPULATION OF SPECIFIC PATIENT SUBGENOTYPES, KIT AND COMPOUND | |
| AR085928A1 (en) | COMBINED THERAPY TO TREAT HCV INFECTIONS (HEPATITIS C VIRUSES) IN A SUBPOBLATION OF SPECIFIC PATIENT SUBGENOTYPES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |